Joint Formulary & PAD

Dalteparin sodium - VTE prevention post hip/knee replacement

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Dalteparin sodium
Indication :
VTE prevention post hip/knee replacement
Group Name :
Keywords :
VTE prophylaxis, venous thromboembolism, Low molecular weight heparins, LMWH, SWLEOC guidelines
Brand Names Include :
Fragmin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Dalteparin sodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat VTE prevention post hip/knee replacement.

Committee Recommendations (1)

27 Oct 10 - Not Set
The use of LMWH to prevent VTE post operatively is considered as red on the traffic light system. The full course of treatment should be supplied by the Acute Trust.